Repurposing ibrutinib: therapeutic effects and implications for translational approaches in Alzheimer 's disease
Hyun-ju Lee1
Hyang-Sook Hoe2
1.Department of Neural Development and Disease,Korea Brain Research Institute(KBRI),Daegu,South Korea2.Department of Neural Development and Disease,Korea Brain Research Institute(KBRI),Daegu,South Korea;Department of Brain and Cognitive Sciences,Daegu Gyeongbuk Institute of Science&Technology,Daegu 42988,South Korea
摘要:Alzheimer's disease (AD) is the most prevalent neurodegenerative disease, and the number of patients with AD is estimated to double by 2060 (Alzheimer's Association, 2022). The AD mortality rate has increased by 145% over the last decade, the largest increase among the ten leading causes of death in the US (Alzheimer's Association, 2022).
机标关键词:ibrutinibalzheimerapproachesdiseaseeffectsimplicationsrepurposingtherapeutic
论文发表日期:2023-10-28
在线出版日期:2025-08-15(本平台首次上网日期,不代表文献的发表时间)
页数:2( 2194-2195 )
